Tuberculosis (TB) remains a severe public health problem worldwide. In Korea, the prevalence of TB is still high despite multiple efforts to combat it \[[@B1], [@B2]\]. In addition, there has been a steady increase in the incidence of strains becoming resistant to drugs \[[@B3]\]. Genotyping is necessary for epidemiologic and clinical purposes and improves the understanding of the epidemiology and control of TB by providing information about transmission \[[@B4]\]. An epidemiologic tool, repetitive sequence-based PCR (rep-PCR), has been recognized as an effective method \[[@B5]\]. Rep-PCR is used to determine the similarity of bacterial strains at the genomic level as the repetitive sequences throughout the genome enable discrimination of interstrain variation on the basis of amplicon size and intensity. Rep-PCR greatly enhances assay reproducibility and strain discrimination compared with other PCR-based platforms. The commercial DiversiLab™ Microbial Typing System (bioMérieux, Marcy l\'Etoile, France) \[[@B6]\] has the advantage of real-time data production and the convenience of partial automation \[[@B7]\]. IS*6110*-based restriction fragment length polymorphism (RFLP) is considered the gold standard and the most widely applied genotyping method for the molecular epidemiology of *Mycobacterium tuberculosis* \[[@B8]\].

In this study, we evaluated the DiversiLab rep-PCR-based system\'s discriminatory ability for *M. tuberculosis* by comparing it with previous data from IS*6110*-RFLP analysis \[[@B9]\]. We studied 89 clinical *M. tuberculosis* isolates collected from 11 university hospitals nationwide in Korea between 2008 and 2009 from epidemiologically unrelated patients. All 89 isolates had already been characterized by IS*6110*-RFLP \[[@B9]\]. According to the manufacturer\'s recommendations, the DiversiLab Fingerprinting Kit (Bacterial Barcodes, Inc., Huston, TX, USA) was used for rep-PCR amplification of non-coding intergenic repetitive elements in the genomic DNA of the isolates. Rep-PCR genomic typing was performed using the DiversiLab system. The DiversiLab system includes fragment separation using microfluidic chips (LabChip device; Caliper Technologies, Inc., Mountain View, CA, USA) and the Agilent B2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA). Results were analyzed using DiversiLab software (version 3.3). Reports, including dendrograms, electropherograms, and virtual gel and scatterplot images, were generated automatically. To evaluate reproducibility, we performed the entire assay, including DNA extraction, PCR, and chip analysis on the bioanalyzer, in duplicate. The percent similarities of the dendrograms were analyzed by Pearson correlation. We used a single numerical index of discrimination on the basis of Simpson\'s index of diversity \[[@B10]\].

The results of the DiversiLab system defined 89 isolates in 8 groups and 1 unique isolate when a similarity level of 95% was applied ([Fig. 1](#F1){ref-type="fig"}). One major group contained 18 isolates. Seventy-six isolates of the Beijing family and 13 isolates of non-Beijing family strains, previously defined by IS*6110*-RFLP \[[@B1]\], were distributed to each group. Therefore, this method was able to discriminate strain variations between Beijing family members. Among the 14 isolates of the K family, which showed unique RFLP patterns and are rather highly prevalent in Korea, 7 (50%) belonged to 1 major group. The reproducibility studies showed identical rep-PCR patterns for each duplicate test with the same strain. The results of cluster analysis did not correlate with any region of strain isolation.

Few publications are available on the performance of the DiversiLab system \[[@B11]-[@B13]\]. Cangelosi et al. \[[@B14]\] evaluated the system as an epidemiologic method for *M. tuberculosis* and *M. avium* complex, indicating that it can replace IS*6110*-RFLP for typing *M. tuberculosis*. In our current study, we showed the usefulness of the DiversiLab system by evaluating its efficacy with 89 *M. tuberculosis* isolates collected nationwide in Korea. The system displayed highly discriminatory results among Beijing family strains that have shown nearly identical IS*6110*-RFLP patterns. IS*6110*-RFLP is considered a gold standard method in strain typing for *M. tuberculosis*; however, discrimination of the Beijing family is unsatisfactory by using this method \[[@B15]\]. Therefore, IS*6110*-RFLP is less useful in Korea, where Beijing family strains are highly prevalent (87 to 95%) \[[@B9], [@B16]\]. The DiversiLab system can be a surrogate tool for epidemiologic analysis of *M. tuberculosis* in Korea. The ability to generate fingerprints in real time, together with the DNA amplification step, enables analysis in the early stages of the event; i.e., suspected cross contamination or outbreak.

Other molecular epidemiologic methods for *M. tuberculosis* strains have been evaluated. Mycobacterial interspersed repetitive units-variable number tandem repeats (MIRU-VNTR) is fairly rapid, requires only small amounts of DNA, and can easily be digitized to share data among laboratories \[[@B17]\]. Single-nucleotide polymorphism (SNP) analysis also provides a powerful strategy for large-scale molecular population studies examining phylogenetic relations among bacterial strains \[[@B18], [@B19]\]. However, the DiversiLab system provides results within 24 hr. Moreover, the DiversiLab system can generate a sensitive and standardized result and is reproducible and highly discriminatory. Thus, it can be used in the molecular epidemiologic investigation of clinical *M. tuberculosis* isolates in Korea.

All reagents used for DiversiLab analysis were purchased from, and technical support was freely provided by, bioMérieux Korea (Seoul, Korea).
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